Validation experiment designed to validate causal mechanisms targeting TARDBP in TDP-43 mutant mice. Primary outcome: neuroinflammatory cytokine profile
Investigation of cGAS/STING pathway activation in TDP-43 mutant mice to validate the role of this innate immune signaling cascade in ALS pathology in vivo. The study examined whether pharmacologic inhibition or genetic deletion of cGAS and STING components could prevent the neuroinflammatory phenotype associated with TDP-43 mutations in the mouse model.
Analysis of TDP-43 mutant mice with pharmacologic inhibition or genetic deletion of cGAS/STING components, assessment of inflammatory markers and pathology
cGAS/STING inhibition reduces neuroinflammation in TDP-43 mutant mice
Decreased inflammatory cytokine levels and reduced pathology
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.